FBLN5

The protein encoded by this gene is a secreted, extracellular matrix protein containing an Arg-Gly-Asp (RGD) motif and calcium-binding EGF-like domains. It promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. It is prominently expressed in developing arteries but less so in adult vessels. However, its expression is reinduced in balloon-injured vessels and atherosclerotic lesions, notably in intimal vascular smooth muscle cells and endothelial cells. Therefore, the protein encoded by this gene may play a role in vascular development and remodeling. Defects in this gene are a cause of autosomal dominant cutis laxa, autosomal recessive cutis laxa type I (CL type I), and age-related macular degeneration type 3 (ARMD3). [provided by RefSeq, Jul 2008]
Full Name
Fibulin 5
Research Area
Essential for elastic fiber formation, is involved in the assembly of continuous elastin (ELN) polymer and promotes the interaction of microfibrils and ELN (PubMed:18185537).

Stabilizes and organizes elastic fibers in the skin, lung and vasculature (By similarity).

Promotes adhesion of endothelial cells through interaction of integrins and the RGD motif. Vascular ligand for integrin receptors which may play a role in vascular development and remodeling (PubMed:10428823).

May act as an adapter that mediates the interaction between FBN1 and ELN (PubMed:17255108).
Biological Process
Cell-matrix adhesion Source: ProtInc
Elastic fiber assembly Source: UniProtKB
Protein localization to cell surface Source: BHF-UCL
Regulation of cell growth Source: Ensembl
Regulation of removal of superoxide radicals Source: BHF-UCL
Secretion Source: UniProtKB
Cellular Location
Secreted; Extracellular matrix. Co-localizes with ELN in elastic fibers.
Involvement in disease
Neuropathy, hereditary, with or without age-related macular degeneration (HNARMD):
An autosomal dominant neuropathy of the Charcot-Marie-Tooth disease group, characterized by distal muscle weakness and atrophy variably affecting the lower and upper limbs. Distal sensory impairment and decreased nerve conduction velocities are present in most but not all patients. Additional variable features are age-related macular degeneration, joint hypermobility, and hyperelastic skin.
Cutis laxa, autosomal dominant, 2 (ADCL2):
A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. Additional variable clinical features are gastrointestinal diverticula, hernia, and genital prolapse. Rare manifestations are pulmonary artery stenosis, aortic aneurysm, bronchiectasis, and emphysema.
Cutis laxa, autosomal recessive, 1A (ARCL1A):
A connective tissue disorder characterized by loose, hyperextensible skin with decreased resilience and elasticity leading to a premature aged appearance. Face, hands, feet, joints, and torso may be differentially affected. The clinical spectrum of autosomal recessive cutis laxa is highly heterogeneous with respect to organ involvement and severity. Type I autosomal recessive cutis laxa is a specific, life-threatening disorder with organ involvement, lung atelectasis and emphysema, diverticula of the gastrointestinal and genitourinary systems, and vascular anomalies. Associated cranial anomalies, late closure of the fontanel, joint laxity, hip dislocation, and inguinal hernia have been observed but are uncommon.
Macular degeneration, age-related, 3 (ARMD3):
A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.
PTM
N-glycosylated.
View more

Anti-FBLN5 antibodies

+ Filters
Loading...
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Mouse, Rat
Clone: 937
Application*: ELISA, IF, IHC, WB
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 3F10A5, 3F8A12
Application*: ELISA, WB, IHC
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-1579
Application*: E, IH, WB
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBXF-2577
Application*: WB, IH
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Mouse
Clone: CBXF-0362
Application*: E, WB, IH
Target: FBLN5
Host: Mouse
Antibody Isotype: IgM
Specificity: Human
Clone: 3F8D5,7F8D5
Application*: E, WB
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: 1G6A4
Application*: E, IH, P, WB
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human, Mouse, Pig, Rat
Clone: CBXF-2178
Application*: E, WB, IH, IF
Target: FBLN5
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human, Mouse
Clone: CBXF-1196
Application*: WB, IP
Target: FBLN5
Host: Rabbit
Antibody Isotype: IgG
Specificity: Human
Clone: CBXF-1232
Application*: WB
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBT541
Application*: WB, P, IF, E
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBT542
Application*: WB, P, IF, E
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG
Specificity: Human
Clone: CBT543
Application*: WB, E
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBT2065
Application*: IH
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG1
Specificity: Human
Clone: CBT4823
Application*: IH
Target: FBLN5
Host: Mouse
Antibody Isotype: IgM
Specificity: Human
Clone: CBT4654
Application*: WB
Target: FBLN5
Host: Mouse
Antibody Isotype: IgG2a
Specificity: Human, Mouse, Rat
Clone: CF163
Application*: ELISA, WB, IHC, IF
More Infomation
Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized) Submit A Review Fig.3 Signaling pathways in cancers. (Creative Biolabs Authorized) Fig.4 Protocols troubleshootings & guides. (Creative Biolabs Authorized)
For Research Use Only. Not For Clinical Use.
(P): Predicted
* Abbreviations
  • AActivation
  • AGAgonist
  • APApoptosis
  • BBlocking
  • BABioassay
  • BIBioimaging
  • CImmunohistochemistry-Frozen Sections
  • CIChromatin Immunoprecipitation
  • CTCytotoxicity
  • CSCostimulation
  • DDepletion
  • DBDot Blot
  • EELISA
  • ECELISA(Cap)
  • EDELISA(Det)
  • ESELISpot
  • EMElectron Microscopy
  • FFlow Cytometry
  • FNFunction Assay
  • GSGel Supershift
  • IInhibition
  • IAEnzyme Immunoassay
  • ICImmunocytochemistry
  • IDImmunodiffusion
  • IEImmunoelectrophoresis
  • IFImmunofluorescence
  • IHImmunohistochemistry
  • IMImmunomicroscopy
  • IOImmunoassay
  • IPImmunoprecipitation
  • ISIntracellular Staining for Flow Cytometry
  • LALuminex Assay
  • LFLateral Flow Immunoassay
  • MMicroarray
  • MCMass Cytometry/CyTOF
  • MDMeDIP
  • MSElectrophoretic Mobility Shift Assay
  • NNeutralization
  • PImmunohistologyp-Paraffin Sections
  • PAPeptide Array
  • PEPeptide ELISA
  • PLProximity Ligation Assay
  • RRadioimmunoassay
  • SStimulation
  • SESandwich ELISA
  • SHIn situ hybridization
  • TCTissue Culture
  • WBWestern Blot
online inquiry
Online Inquiry